OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 66 filers reported holding OCULAR THERAPEUTIX INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,431 | -27.0% | 35,806 | +20.0% | 0.00% | – |
| Q2 2023 | $153,984 | -42.8% | 29,842 | -41.6% | 0.00% | – |
| Q1 2023 | $269,166 | +174.5% | 51,075 | +46.4% | 0.00% | – |
| Q4 2022 | $98,061 | -31.4% | 34,897 | +1.5% | 0.00% | – |
| Q3 2022 | $143,000 | -10.1% | 34,382 | -13.0% | 0.00% | – |
| Q2 2022 | $159,000 | -28.4% | 39,528 | -11.7% | 0.00% | – |
| Q1 2022 | $222,000 | -35.5% | 44,783 | -9.5% | 0.00% | – |
| Q4 2021 | $344,000 | -33.1% | 49,485 | -3.8% | 0.00% | – |
| Q3 2021 | $514,000 | -35.9% | 51,460 | -9.0% | 0.00% | – |
| Q2 2021 | $802,000 | -7.6% | 56,527 | +6.8% | 0.00% | – |
| Q1 2021 | $868,000 | -31.6% | 52,922 | -13.7% | 0.00% | -100.0% |
| Q4 2020 | $1,269,000 | +3.3% | 61,297 | -62.1% | 0.00% | 0.0% |
| Q3 2020 | $1,229,000 | +38.1% | 161,533 | +51.3% | 0.00% | 0.0% |
| Q2 2020 | $890,000 | +1119.2% | 106,773 | +629.1% | 0.00% | – |
| Q1 2020 | $73,000 | +23.7% | 14,645 | -4.6% | 0.00% | – |
| Q4 2019 | $59,000 | +73.5% | 15,348 | +31.2% | 0.00% | – |
| Q3 2019 | $34,000 | -71.7% | 11,696 | -57.9% | 0.00% | – |
| Q2 2019 | $120,000 | -28.6% | 27,795 | -35.4% | 0.00% | – |
| Q1 2019 | $168,000 | +5.7% | 43,038 | +6.6% | 0.00% | – |
| Q4 2018 | $159,000 | -83.8% | 40,361 | -71.8% | 0.00% | – |
| Q3 2018 | $983,000 | +27.5% | 143,221 | +25.1% | 0.00% | – |
| Q2 2018 | $771,000 | +217.3% | 114,514 | +203.5% | 0.00% | – |
| Q1 2018 | $243,000 | +10.0% | 37,728 | -24.6% | 0.00% | – |
| Q4 2017 | $221,000 | +81.1% | 50,065 | +148.7% | 0.00% | – |
| Q3 2017 | $122,000 | -89.3% | 20,127 | -83.6% | 0.00% | -100.0% |
| Q2 2017 | $1,138,000 | -8.2% | 122,989 | -8.0% | 0.00% | 0.0% |
| Q1 2017 | $1,239,000 | +21.7% | 133,677 | +9.7% | 0.00% | 0.0% |
| Q4 2016 | $1,018,000 | +46.9% | 121,892 | +20.7% | 0.00% | – |
| Q3 2016 | $693,000 | +9.3% | 100,961 | -21.2% | 0.00% | – |
| Q2 2016 | $634,000 | -34.0% | 128,187 | +28.7% | 0.00% | -100.0% |
| Q1 2016 | $961,000 | +2.5% | 99,629 | -0.7% | 0.00% | 0.0% |
| Q4 2015 | $938,000 | -33.6% | 100,361 | -0.1% | 0.00% | 0.0% |
| Q3 2015 | $1,412,000 | -32.5% | 100,496 | +1.0% | 0.00% | 0.0% |
| Q2 2015 | $2,092,000 | -49.4% | 99,535 | +1.0% | 0.00% | -66.7% |
| Q1 2015 | $4,137,000 | +82.6% | 98,567 | +2.3% | 0.00% | +200.0% |
| Q4 2014 | $2,266,000 | +51.4% | 96,358 | -3.6% | 0.00% | 0.0% |
| Q3 2014 | $1,497,000 | – | 100,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |